Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Apolipoprotein E in cardiometabolic and neurological health and diseases
J Alagarsamy, A Jaeschke, DY Hui - International Journal of Molecular …, 2022 - mdpi.com
A preponderance of evidence obtained from genetically modified mice and human
population studies reveals the association of apolipoprotein E (apoE) deficiency and …
population studies reveals the association of apolipoprotein E (apoE) deficiency and …
Association between genetic variants and diabetes mellitus in Iranian populations: a systematic review of observational studies
M Khodaeian, S Enayati… - Journal of diabetes …, 2015 - Wiley Online Library
Introduction. Diabetes mellitus as the most prevalent metabolic disease is a multifactorial
disease which is influenced by environmental and genetic factors. In this systematic review …
disease which is influenced by environmental and genetic factors. In this systematic review …
Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease
D El-Lebedy, HM Raslan, AM Mohammed - Cardiovascular diabetology, 2016 - Springer
Background Lipoprotein-related mechanisms have been associated with damage to the
cardiovascular system in diabetic patients. Apolipoprotein E gene which affects the …
cardiovascular system in diabetic patients. Apolipoprotein E gene which affects the …
Apolipoprotein E4 impairs macrophage efferocytosis and potentiates apoptosis by accelerating endoplasmic reticulum stress
JG Cash, DG Kuhel, JE Basford, A Jaeschke… - Journal of Biological …, 2012 - ASBMB
Apolipoprotein (apo) E4 is a major genetic risk factor for a wide spectrum of inflammatory
metabolic diseases, including atherosclerosis, diabetes, and Alzheimer disease. This study …
metabolic diseases, including atherosclerosis, diabetes, and Alzheimer disease. This study …
Diabetes mellitus and risk of incident dementia in APOE ɛ4 carriers: an updated meta-analysis
A Rashtchian, MH Etemadi, E Asadi, S Binaei… - BMC neuroscience, 2024 - Springer
Background and aim Diabetes raises the risk of dementia, mortality, and cognitive decline in
the elderly, potentially because of hereditary variables such as APOE. In this study, we aim …
the elderly, potentially because of hereditary variables such as APOE. In this study, we aim …
Apolipoprotein E polymorphisms and type 2 diabetes: a meta-analysis of 30 studies including 5423 cases and 8197 controls
Type 2 diabetes mellitus (T2DM) is a highly complicated metabolic disorder for which there
is worldwide effort for the identification of susceptibility genes. Polymorphisms of the …
is worldwide effort for the identification of susceptibility genes. Polymorphisms of the …
Dissecting the association of apolipoprotein e gene polymorphisms with type 2 diabetes mellitus and coronary artery disease
L Wu, Y Zhang, H Zhao, G Rong, P Huang… - Frontiers in …, 2022 - frontiersin.org
Background Apolipoprotein E (APOE) gene mediates lipoprotein clearance and is one of the
most studied candidate genes for type 2 diabetes mellitus (T2DM) and coronary artery …
most studied candidate genes for type 2 diabetes mellitus (T2DM) and coronary artery …
Association of Apolipoprotein E gene polymorphism with the risk of T2DM and obesity among Egyptian subjects
AA Galal, AA Abd Elmajeed, RA Elbaz, AM Wafa… - Gene, 2021 - Elsevier
Background Numerous reports investigated the involvement of apolipoprotein E (APOE)
polymorphisms with elevated risk of type 2 diabetes mellitus (T2DM) and obesity. The …
polymorphisms with elevated risk of type 2 diabetes mellitus (T2DM) and obesity. The …
Dissociation of apolipoprotein E oligomers to monomer is required for high-affinity binding to phospholipid vesicles
The apolipoprotein apoE plays a key role in cholesterol and lipid metabolism. There are
three isoforms of this protein, one of which, apoE4, is the major risk factor for Alzheimer's …
three isoforms of this protein, one of which, apoE4, is the major risk factor for Alzheimer's …
Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease
A non-optimal plasma concentration of lipids is among the major modifiable risk factors of
atherosclerosis. Therefore, the prevention of cardiovascular disease by means of lipid …
atherosclerosis. Therefore, the prevention of cardiovascular disease by means of lipid …